bhukap

Jim Cramer's Mad Money In-Depth. 11/1/07: Brocade Saddles Up

Kramer keeps supporting Celgene but the news is out on its only two drugs, Revlimid and Thalidomide both of limited use outside of myeloma and some uncommon blood disorders. Its stock is in my judgment very overpriced. I own 5000 shares of Millenium and I am a happy camper today. I am also an oncologist and find Celgene's pricing for its drugs and its corporate behavior outrageous. Remember Velcade is IV and revlimid is po. Given equivalency which do you think an oncologist would choose?